Information Needs of Black Prostate Cancer Patients Receiving Treatment Within the South African Public Healthcare System

Taljaard, M. V.; Lovric, Germaine T.; Makenzi, Aviwe M; Kawinga, Prudence

doi:10.1007/s40487-020-00125-1

Cited by 3 publications

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…PCa is the fifth leading cause of death in men and the second most common disease worldwide with an estimated 26,730 deaths in the USA ( 6 ). Although PCa is a silent killer in men because it’s asymptomatic in most patients ( 7 ), the possibility of recovery is very high when diagnosed at early stages ( 7 ). In the United Arab Emirates (UAE), there is a lack of prostate disease epidemiology and associated risk factors.…”

Section: Introductionmentioning

confidence: 99%

Risks of prostate cancer and mortality in the city of Sharjah, United Arab Emirates

Al Shareef,

Al-Shahrabi,

Saheb Sharif-Askari

et al. 2023

Front. Oncol.

View full text Add to dashboard Cite

BackgroundProstatic hyperplasia (BPH) and prostate cancer (PCa) are common age-related diseases in men. According to World Health Organization (WHO), PCa is the second most common cancer among Emirati men. This study aimed to identify the risk factors associated with PCa and mortality in a cohort diagnosed with PCa between 2012 and 2021 in Sharjah, United Arab Emirates (UAE).MethodsThe data collected in this retrospective case-control study included patient demographics and comorbidities, as well as PCa markers such as prostate-specific antigen (PSA), prostate volume, prostate-specific antigen density (PSAD), and Gleason scores. Risk factors for PCa were assessed using multivariate logistic regression analysis, and factors associated with all-cause mortality in PCa patients were evaluated using Cox-proportional hazard analysis.ResultsOf the 192 cases analyzed in this study, 88 were diagnosed with PCa and 104 were diagnosed with BPH. Regarding risk factors for PCa, a higher risk of PCa was associated with age 65 or older (OR=2.76, 95% confidence interval (CI): 1.04-7.30; P=0.038) and serum PSAD greater than 0.1 ng/mL2 (OR=3.48, 95% CI:1.66-7.32; P=0.001), whereas being of UAE nationals (OR=0.40, 95% CI:0.18-0.88; P=0.029) were associated with lower risk of PCa, after adjusting for patient demographics and comorbidities. Moreover, regarding cancer markers, higher serum PSA level (P=0.003) and smaller prostate volume (P=0.028) were associated with a higher risk of PCa, after adjusting with patients’ age and BMI. Additionally, a high-grade Gleason score was associated with an increased risk of all-cause mortality after adjusting for patient’s age and BMI (hazard ratio, aHR= 2.3, 95% CI:1.3-4.1; P= 0.016).ConclusionThis study found that age 65 or older and serum PSAD greater than 0.1 ng/mL2 are risk factors for PCa, while UAE nationality is associated with a lower risk. PSAD may be a better screening marker for PCa compared to traditional markers such as PSA and prostate volume.

show abstract

Section: Introductionmentioning

confidence: 99%

Risks of prostate cancer and mortality in the city of Sharjah, United Arab Emirates

Al Shareef,

Al-Shahrabi,

Saheb Sharif-Askari

et al. 2023

Front. Oncol.

View full text Add to dashboard Cite

show abstract

A Scoping Review of Stigma Related to Prostate Cancer in Black Men

Bamidele,

Greenley,

Ukoha-Kalu

et al. 2024

J. Racial and Ethnic Health Disparities

View full text Add to dashboard Cite

Background Prostate cancer (CaP) disproportionately affects 1-in-4 Black men and is a stigmatised disease within their communities. Yet, Black men are underrepresented in CaP research concerning stigma, which necessitates a scoping review to map available evidence on this topic to inform future research. Aims To map published literature on stigma related to CaP in Black men to understand their experiences and/or perceptions and identify directions for future research. Methods A scoping review was conducted using the five-step framework by Arksey and O’Malley. Studies published in English addressing stigma related to CaP from the perspectives of Black men and/or their families were included. We searched six databases including Medline, Embase, PsycInfo, CINAHL, Web of Science Core Collection and Google Scholar, from inception to April 2023. Citation searches were also conducted. Two independent reviewers conducted screening and data extraction. Data was synthesised using descriptive content analysis. Results Thirty-four eligible studies conducted in the USA, UK, Trinidad and Tobago, South Africa, Cameroon and Canada from 1995 to 2023 were included. A total of 1867 Black men with/without a CaP diagnosis and 145 adult partners were included. Review findings showed a complex intersection of self-stigma, public stigma and structural stigma impacted Black men’s perceptions of their masculinity. While men’s experiences/perceptions of stigma varied depending on their illness status, there were commonalities in their masculinity concerns (underpinned by stigma), which influenced their attitude towards digital rectal examination, post-treatment side effects and social interactions on CaP. These have implications for public health messaging on CaP within Black communities, as well as patient-provider interactions with the men. Conclusions This novel review highlights the need to pay attention to how CaP is presented to Black men and their communities using avenues and languages that are culturally acceptable and empower them to negotiate self-stigma, public stigma and structural stigma related to CaP. Directions for further research were also identified.

show abstract